MC

Muhlenkamp & Co Portfolio holdings

AUM $320M
This Quarter Return
+12.96%
1 Year Return
+26.1%
3 Year Return
5 Year Return
10 Year Return
AUM
$270M
AUM Growth
+$270M
Cap. Flow
-$22.6M
Cap. Flow %
-8.36%
Top 10 Hldgs %
47.67%
Holding
38
New
1
Increased
18
Reduced
12
Closed
5

Sector Composition

1 Technology 18.7%
2 Healthcare 18.22%
3 Industrials 17.47%
4 Consumer Discretionary 15.34%
5 Financials 11.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WAB icon
26
Wabtec
WAB
$33.1B
$4.89M 1.81%
55,276
+312
+0.6% +$27.6K
FNV icon
27
Franco-Nevada
FNV
$36.3B
$3.18M 1.17%
20,853
+3,485
+20% +$531K
RGLD icon
28
Royal Gold
RGLD
$11.8B
$2.76M 1.02%
24,350
+4,426
+22% +$502K
PFE icon
29
Pfizer
PFE
$141B
$1.23M 0.45%
24,379
+640
+3% +$32.3K
MS icon
30
Morgan Stanley
MS
$240B
$1.11M 0.41%
10,805
EQC
31
DELISTED
Equity Commonwealth
EQC
$1.01M 0.37%
+38,348
New +$1.01M
EPD icon
32
Enterprise Products Partners
EPD
$69.6B
$552K 0.2%
24,855
RUSHB icon
33
Rush Enterprises Class B
RUSHB
$4.52B
$285K 0.11%
6,742
+48
+0.7% +$2.03K
BIDU icon
34
Baidu
BIDU
$32.8B
-27,033
Closed -$5.85M
CTSH icon
35
Cognizant
CTSH
$35.3B
-8,998
Closed -$737K
GILD icon
36
Gilead Sciences
GILD
$140B
-50,803
Closed -$2.96M
JAZZ icon
37
Jazz Pharmaceuticals
JAZZ
$7.75B
-50,460
Closed -$8.33M
BMY.RT
38
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-69,403
Closed -$48K